Firmagon Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - Νεοπλάσματα του προστάτη - Ενδοκρινική θεραπεία - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Degarelix Accord Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - Νεοπλάσματα του προστάτη - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

FIRMAGON 80MG/VIAL PS.INJ.SOL Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

firmagon 80mg/vial ps.inj.sol

ferring pharmaceuticals a/s, denmark - degarelix - ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 80mg/vial - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

FIRMAGON 120MG/VIAL PS.INJ.SOL Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

firmagon 120mg/vial ps.inj.sol

ferring pharmaceuticals a/s, denmark - degarelix - ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 120mg/vial - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ